IP Library Granted Patent US 11,406,122
Granted Patent B2
US 11,406,122 · App. 15/301,480 · Granted Aug 9, 2022

Autoimmunity and multiple sclerosis treatment

Inventors: Valter D. Longo (Playa del Rey, CA); In Young Choi (Garden Grove, CA)
Assignee: UNIVERSITY OF SOUTHERN CALIFORNIA
A23L33/30A61K38/00A61K45/06G01N33/564A23V2002/00G01N2800/285
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,406,122
App. No.
15/301,480
Granted
Aug 9, 2022
Kind
B2
Abstract

A method for alleviating a symptom of multiple sclerosis or other autoimmune or inflammatory disease includes a step of identifying a subject having multiple sclerosis or other autoimmune diseases. A fasting mimicking diet is administered to the subject for a first predetermined time period, the fasting mimicking diet providing less than 50% of the subject's normal caloric intake. A non-fasting diet is administered to the subject for a second time period following the first time period. The non-fasting diet provides the subject greater than 60 percent of the subject's normal caloric intake but a calorie intake necessary for the subject to return to a normal healthy weight.

Claims (40)

1. A method for alleviating a symptom of autoimmunity, the method comprising:

identifying a subject having an autoimmune disease;

administering a first diet to the subject for a first predetermined time period of three to seven days, the first diet providing less than 100 grams of carbohydrates with less than 30 g of sugars per day and less than 28 g of proteins/amino acids per day, the first diet providing greater than 30 percent of the subject's normal caloric intake and less than 50% of the subject's normal caloric intake, with 52.4 to 82.4% of the total daily caloric intake being fat, 10 to 16.6% of the total daily caloric intake being carbohydrates, and 8-15% of the total daily caloric intake being protein, the first diet also providing 10-15 g of monounsaturated fats per day, 3-5 g of polyunsaturated fats per day and 1-6 grams of saturated fats per day; and

administering a non-fasting diet to the subject for a second time period of three to sixteen weeks following the first predetermined time period, the non-fasting diet providing the subject with normal caloric intake, the normal caloric intake being the number of calories the subject consumes to maintain the subject's weight.

2. The method of claim 1 wherein the first diet is a ketogenic diet.

3. The method of claim 1 wherein the first predetermined time period is about 5 days.

4. The method of claim 3 wherein on a first day of the first predetermined time period of the first diet, the subject is provided with 4.5-7 kilocalories per pound of the subject.

5. The method of claim 3 wherein for each day on days 2-5 of the first diet the subject is provided with 3-5 kilocalories per pound of the subject's weight.

6. The method of claim 4 wherein the first predetermined time period of the first diet provides the subject with less than 100 grams of carbohydrates and less than 20 g of sugars per day, and less than 18 g of proteins/amino acids per day.

7. The method of claim 1 wherein the first predetermined time period is about 4 days.

8. The method of claim 7 wherein on a first day of the first predetermined time period of the first diet, the subject is provided with 3.5-5 kilocalories per pound of the subject.

9. The method of claim 8 wherein for each day from days 2-4 the first diet provides 2.4 to 4 kilocalories per pound of the subject.

10. The method of claim 1 wherein the subject is a mammal.

11. The method of claim 1 wherein the subject is a human.

12. The method of claim 1 wherein the autoimmune disease is multiple sclerosis.

13. A method for treating multiple sclerosis comprising:

identifying a subject having multiple sclerosis;

administering a first diet to the subject for a first predetermined time period of three to seven days, the first diet providing greater than 30 percent of the subject's normal caloric intake and less than 50% of the subject's normal caloric intake restricting both proteins/amino acid and carbohydrate intake to less than 30 g of sugars per day and less than 28 g of proteins per day, the first diet also providing 10-15 g of monounsaturated fats per day, 3-5 g of polyunsaturated fats per day and 1-6 grams of saturated fats per day, the subject's normal caloric intake being the number of calories the subject consumes to maintain the subject's weight; and

administering a non-fasting diet to the subject for a second time period of three to sixteen weeks following the first predetermined time period, the non-fasting diet providing the subject greater than 60 percent of the subject's normal caloric intake but a calorie intake necessary for the subject to return to a normal healthy weight.

14. A method for treating T-cell mediated disease comprising:

identifying a subject having;

administering a first diet to the subject for a first predetermined time period of three to seven days, the first diet providing greater than 30 percent of the subject's normal caloric intake and less than 50% of the subject's normal caloric intake restricting both protein/amino acids and carbohydrate intake to less than 30 g of sugars per day and less than 28 g of proteins/amino acids per day, the first diet also providing 10-15 g of monounsaturated fats per day, 3-5 g of polyunsaturated fats per day and 1-6 grams of saturated fats per day; and

administering a non-fasting diet to the subject for a second time period of three to sixteen weeks following the first predetermined time period, the non-fasting diet providing the subject greater than 60 percent of the subject's normal caloric intake but a calorie intake necessary for the subject to return to a normal healthy weight, the subject's normal caloric intake being the number of calories the subject consumes to maintain the subject's weight.

15. The method of claim 14 wherein the T-cell mediated disease is an autoimmune disease.

16. A method for alleviating a symptom of autoimmunity, method comprising:

identifying a subject having an autoimmune disease;

administering a first diet to the subject for a first predetermined time period of three to seven days, the first diet being a ketogenic diet, the first diet providing greater than 30 percent of the subject's normal caloric intake and less than 50% of the subject's normal caloric intake, with 52.4 to 82.4% of the total daily caloric intake being fat, 10 to 16.6% of the total daily caloric intake being carbohydrates, and 8-15% of the total daily caloric intake being protein, the first diet also providing 10-15 g of monounsaturated fats per day, 3-5 g of polyunsaturated fats per day and 1-6 grams of saturated fats per day; and

administering a non-fasting diet to the subject for a second time period of three to sixteen weeks following the first predetermined time period, the non-fasting diet providing the subject with normal caloric intake, the normal caloric intake being the number of calories the subject consumes to maintain the subject's weight.

17. A method for alleviating a symptom of autoimmunity, the method comprising:

identifying a subject having an autoimmune or inflammatory disease;

administering a first diet to the subject for a first predetermined time period of 3 to 5 days, the first diet providing greater than 20 percent of the subject's normal caloric intake and less than 40% of the subject's normal caloric intake, the first diet providing less than 100 grams of carbohydrates with less than 30 g of sugars per day and less than 28 g of proteins/amino acids per day, the first diet also providing 10-15 g of monounsaturated fats per day, 3-5 g of polyunsaturated fats per day and 1-6 grams of saturated fats per day; and

administering a non-fasting diet to the subject for a second time period of three to sixteen weeks following the first predetermined time period, the non-fasting diet providing the subject with 1600 to 2400 kilocalories per day.

18. A method for alleviating a symptom of autoimmunity, the method comprising:

identifying a subject having an autoimmune disease;

administering a first diet to the subject for a first predetermined time period of three to seven days, the first diet providing less than 100 grams of carbohydrates with less than 30 g of sugars per day and less than 28 g of proteins/amino acids per day, the first diet providing greater than 10 percent of the subject's normal caloric intake and less than 35% of the subject's normal caloric intake, with 52.4 to 82.4% of the total daily caloric intake being fat, 10 to 16.6% of the total daily caloric intake being carbohydrates, and 8-15% of the total daily caloric intake being protein, the first diet also providing 20-30 grams of monounsaturated fats per day, 6-10 g of polyunsaturated fats per day, and 2-12 g of saturated fats per day; and

administering a non-fasting diet to the subject for a second time period of three to sixteen weeks following the first predetermined time period, the non-fasting diet providing the subject with normal caloric intake, the normal caloric intake being the number of calories the subject consumes to maintain the subject's weight.

19. A method for alleviating a symptom of autoimmunity, the method comprising:

identifying a subject having an autoimmune disease;

administering a first diet to the subject for a first predetermined time period of three to seven days, the first diet providing greater than 10 percent of the subject's normal caloric intake and less than 35% of the subject's normal caloric intake, the first diet providing less than 100 grams of carbohydrates with less than 25 g of sugars per day and less than 23 g of proteins/amino acids per day, the first diet providing less than 60% of the subject's normal caloric intake, with 52.4 to 82.4% of the total daily caloric intake being fat, 10 to 16.6% of the total daily caloric intake being carbohydrates, and 8-15% of the total daily caloric intake being protein, the first diet also providing 16-25 grams of monounsaturated fats per day, 4.8-8 g of polyunsaturated fats and 1-10 g of saturated fats per day; and

administering a non-fasting diet to the subject for a second time period of three to sixteen weeks following the first predetermined time period, the non-fasting diet providing the subject with normal caloric intake, the normal caloric intake being the number of calories the subject consumes to maintain the subject's weight.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 2, 2023
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 064467/0786 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SECOND INVENTOR EXECUTION DATE PREVIOUSLY RECORDED AT REEL: 042709 FRAME: 0112. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 21, 2017
From: LONGO, VALTER D.; CHOI, IN YOUNG
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 042929/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2017
From: LONGO, VALTER D.; CHOI, IN YOUNG
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 042709/0112 →
Continuity (2)
Provisional Application 61974189 · Apr 2, 2014
Related Publication 20170027217A1 · Feb 2, 2017